Trials / Sponsors / Zhejiang Haichang Biotech Co., Ltd.
Zhejiang Haichang Biotech Co., Ltd.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC Hepato Cellular Carcinoma (HCC), Renal Cell Cancer | Phase 2 | 2026-06-01 |
| Recruiting | Phase 2 Study of WGI-0301 for Advanced HCC Advanced Hepatocellular Carcinoma (HCC) | Phase 2 | 2024-07-31 |
| Unknown | A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patie Advanced Solid Tumors | Phase 1 | 2022-08-01 |